KELLY CRAWFORD: Open Payments
NPI 1225558588 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 160 payments from 22 companies in 2025. Trend: 2023 $2,397 · 2024 $2,663 · 2025 $2,415
Food & beverage: $2,415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $557 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $277 |
| Aimmune Therapeutics, Inc. | 9 | $174 |
| GENZYME CORPORATION | 8 | $163 |
| Janssen Biotech, Inc. | 10 | $162 |
| Ardelyx, Inc. | 11 | $154 |
| Phathom Pharmaceuticals, Inc. | 9 | $119 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Lilly USA, LLC | 6 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
Products named: XIFAXAN, DUPIXENT, TREMFYA, RINVOQ, IBSRELA, MAVYRET, VOQUEZNA, OMVOH.
Industry payments across SC — which companies pay providers there.
